Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125830651 | 12583065 | 1 | I | 201607 | 20160714 | 20160722 | 20160722 | EXP | GB-ABBVIE-16P-167-1683072-00 | ABBVIE | 38.00 | YR | F | Y | 53.50000 | KG | 20160722 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125830651 | 12583065 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | 2750399 | 50662 | 500 | MG | BID | |||||||
| 125830651 | 12583065 | 2 | C | CO-AMOXICLAV | AMOXICILLINCLAVULANIC ACID | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125830651 | 12583065 | 1 | Lower respiratory tract infection |
| 125830651 | 12583065 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125830651 | 12583065 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125830651 | 12583065 | Asthenia | |
| 125830651 | 12583065 | Decreased appetite | |
| 125830651 | 12583065 | Diarrhoea | |
| 125830651 | 12583065 | Headache | |
| 125830651 | 12583065 | Hyperhidrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125830651 | 12583065 | 1 | 20160704 | 0 |